Organigram Launches Edison Vapes and BOXHOT Pastilles in Australian Medical Cannabis Market
Organigram has introduced Edison and BOXHOT medical cannabis vapes and pastilles to the Australian market, marking its first distribution of these brands in the region. This expansion aims to leverage Australia’s growing medical cannabis program through partnerships with local licensed distributors to drive international revenue growth.
1. Launch of Edison Vapes and BOXHOT Pastilles
Organigram has expanded its Australian presence by rolling out Edison-branded medical cannabis vapes alongside BOXHOT pastilles. These offerings represent the company’s first branded delivery formats tailored specifically for the country’s licensed medical program.
2. Distribution and Market Strategy
The new products will be distributed through licensed clinics and wholesalers across Australia, targeting the nation’s established patient base. This strategy leverages Organigram’s global supply chain and recent local regulatory approvals to support its broader international growth objectives.